A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, May 18 | 10 – 11 a.m. ET | Online Rapid advances and decreasing costs of human genome sequencing technologies are accelerating the integration of genomics into clinical practice. Although genomic sequencing has demonstrated utility as an indication-based diagnostic tool for certain diseases, the full potential of DNA sequencing for population-level screening is yet […]
Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery – Current Status and the Path Forward Thursday, February 15 | 1-2 p.m. ET | Virtual Speakers: Paul C. Adams, MD, Professor, Division of Gastroenterology, Western University Gail P. Jarvik, MD, PhD, Head and Professor, Division of Medical Genetics, University of Washington […]
GMKB